An aspect of the invention is to provide a method of treating elevated iNOS associated diseases including autoimmune, chronic inflammation, neurodegeneration, or cardiovascular disease. In particular, aspects of the invention relate to the use of therapeutic agents comprising galacto-rhamnogalacturonate for the treatment of diseases associated with elevated iNOS, including autoimmune, chronic inflammation, neurodegeneration, or cardiovascular disease. .
展开▼
